BilobetinCAS# 521-32-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 521-32-4 | SDF | Download SDF |
| PubChem ID | 5315459 | Appearance | Yellow powder |
| Formula | C31H20O10 | M.Wt | 552.5 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Synonyms | 4'-O-Methylamentoflavone; 4',5,5'',7,7''-Pentahydroxy 4'''-methoxy 3''',8-biflavone | ||
| Solubility | Soluble in acetonitrile; slightly soluble in water | ||
| Chemical Name | 8-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one | ||
| SMILES | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC=C(C=C6)O)O)O | ||
| Standard InChIKey | IWEIJEPIYMAGTH-UHFFFAOYSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Bilobetin treatment ameliorates hyperlipidaemia, lipotoxicity and insulin resistance in rats by stimulating PPARα-mediated lipid catabolism. |
| Targets | PPAR | cAMP |
| In vivo | Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet.[Pubmed: 22091731]Br J Pharmacol. 2012 Apr;165(8):2692-706.The amelioration of insulin resistance by Bilobetin is closely related to its hypolipidaemic effect. The aim of the present study was to determine the insulin-sensitizing mechanism of Bilobetin by elucidating its effect on lipid metabolism.
|
Bilobetin Dilution Calculator
Bilobetin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.81 mL | 9.0498 mL | 18.0995 mL | 36.1991 mL | 45.2489 mL |
| 5 mM | 0.362 mL | 1.81 mL | 3.6199 mL | 7.2398 mL | 9.0498 mL |
| 10 mM | 0.181 mL | 0.905 mL | 1.81 mL | 3.6199 mL | 4.5249 mL |
| 50 mM | 0.0362 mL | 0.181 mL | 0.362 mL | 0.724 mL | 0.905 mL |
| 100 mM | 0.0181 mL | 0.0905 mL | 0.181 mL | 0.362 mL | 0.4525 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Stanolone
Catalog No.:BCC9153
CAS No.:521-18-6
- Androstenediol
Catalog No.:BCC8828
CAS No.:521-17-5
- Dromostanolone propionate
Catalog No.:BCC8954
CAS No.:521-12-0
- Mestanolone
Catalog No.:BCC9022
CAS No.:521-11-9
- 2-Hydroxy-7-O-methylscillascillin
Catalog No.:BCN5659
CAS No.:52096-50-1
- H-Val-pNA
Catalog No.:BCC3139
CAS No.:52084-13-6
- NCS-382
Catalog No.:BCC6794
CAS No.:520505-01-5
- Isoschaftoside
Catalog No.:BCN3011
CAS No.:52012-29-0
- Medroxyprogesterone
Catalog No.:BCC5231
CAS No.:520-85-4
- Echimidine
Catalog No.:BCN1967
CAS No.:520-68-3
- Rosmarinine
Catalog No.:BCN2124
CAS No.:520-65-0
- Spartioidine
Catalog No.:BCN2134
CAS No.:520-59-2
- Sciadopitysin
Catalog No.:BCN5662
CAS No.:521-34-6
- Cannabinol
Catalog No.:BCN7968
CAS No.:521-35-7
- Pedicin
Catalog No.:BCN4845
CAS No.:521-51-7
- Vulpic acid
Catalog No.:BCN6546
CAS No.:521-52-8
- Physcion
Catalog No.:BCN5663
CAS No.:521-61-9
- Frangulin A
Catalog No.:BCC8174
CAS No.:521-62-0
- Cinnamoylcocaine
Catalog No.:BCN1429
CAS No.:521-67-5
- Broxyquinoline
Catalog No.:BCC4642
CAS No.:521-74-4
- Karanjin
Catalog No.:BCN8370
CAS No.:521-88-0
- 2,4-Dihydroxy-6-methoxy-3-formylacetophenone
Catalog No.:BCN1430
CAS No.:52117-67-6
- 3-O-Acetylpinobanksin
Catalog No.:BCN5660
CAS No.:52117-69-8
- H-Tyr(Bzl)-OBzl.HCl
Catalog No.:BCC3131
CAS No.:52142-01-5
Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARalpha in rats fed a high-fat diet.[Pubmed:22091731]
Br J Pharmacol. 2012 Apr;165(8):2692-706.
BACKGROUND AND PURPOSE: The amelioration of insulin resistance by Bilobetin is closely related to its hypolipidaemic effect. The aim of the present study was to determine the insulin-sensitizing mechanism of Bilobetin by elucidating its effect on lipid metabolism. EXPERIMENTAL APPROACH: Rats fed a high-fat diet were treated with Bilobetin for either 4 or 14 days before applying a hyperinsulinaemic-euglycaemic clamp. Triglyceride and fatty acids labelled with radioactive isotopes were used to track the transportation and the fate of lipids in tissues. The activity of lipid metabolism-related enzymes and beta-oxidation rate were measured. Western blot was used to investigate the phosphorylation, translocation and expression of PPARalpha in several tissues and cultured cells. The location of amino acid residues subjected to phosphorylation in PPARalpha was also studied. KEY RESULTS: Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in beta-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARalpha accompanied by elevated cAMP level and PKA activity. Threonine-129-alanine and/or serine-163-alanine mutations on the PPARalpha genes and PKA inhibitors prevented the effects of Bilobetin on PPARalpha. However, cells overexpressing PKA appeared to stimulate the phosphorylation, nuclear translocation and activity of PPARalpha. CONCLUSIONS AND IMPLICATIONS: Bilobetin treatment ameliorates hyperlipidaemia, lipotoxicity and insulin resistance in rats by stimulating PPARalpha-mediated lipid catabolism. PKA activation is crucial for this process.
